Allergy Therapeutics (FRA:HHU) COGS-to-Revenue : 0.39 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Allergy Therapeutics COGS-to-Revenue?

Allergy Therapeutics's Cost of Goods Sold for the six months ended in Dec. 2023 was €15.15 Mil. Its Revenue for the six months ended in Dec. 2023 was €38.97 Mil.

Allergy Therapeutics's COGS to Revenue for the six months ended in Dec. 2023 was 0.39.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Allergy Therapeutics's Gross Margin % for the six months ended in Dec. 2023 was 61.12%.

Allergy Therapeutics COGS-to-Revenue Historical Data

The historical data trend for Allergy Therapeutics's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics COGS-to-Revenue Chart

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

COGS-to-Revenue

Get a 7-Day Free Trial

0.25

0.26

0.32

0.44

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.26	0.44	0.35	0.62	0.39

Allergy Therapeutics COGS-to-Revenue Calculation

Allergy Therapeutics's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	30.699	/	69.443
	=	0.44

Allergy Therapeutics's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	15.15	/	38.969
	=	0.39

Allergy Therapeutics (FRA:HHU) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Allergy Therapeutics's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	15.15 / 38.969
	=	61.12 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Allergy Therapeutics COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (FRA:HHU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (FRA:HHU) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

AGY:UK HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (FRA:HHU) Headlines

No Headlines